Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ascendis Health's gross profit for the
six
months ended in Jun. 2023 was R293 Mil. Ascendis Health's gross profit for the trailing twelve months (TTM) ended in Jun. 2023 was R605 Mil.
Gross Margin % is calculated as gross profit divided by its revenue. Ascendis Health's gross profit for the
six
months ended in Jun. 2023 was R293 Mil. Ascendis Health's Revenue for the
six
months ended in Jun. 2023 was R758 Mil. Therefore, Ascendis Health's Gross Margin % for the quarter that ended in Jun. 2023 was 38.59%.
Ascendis Health had a gross margin of 38.59% for the quarter that ended in Jun. 2023 => Competition eroding margins
Ascendis Health (JSE:ASC) Gross Profit Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Ascendis Health had a gross margin of 38.59% for the quarter that ended in Jun. 2023 => Competition eroding margins
Ascendis Health Gross Profit Related Terms
Ascendis Health Gross Profit Historical Data
* Premium members only.
The historical data trend for Ascendis Health's Gross Profit can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JSE:ASC vs PHBI, GCAN, SGBI: Gross Profit Comparison
For the Medical Distribution subindustry, Ascendis Health's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ascendis Health Gross Profit vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Ascendis Health's Gross Profit distribution charts can be found below:
* The bar in red indicates where Ascendis Health's Gross Profit falls into.
Gross Profit for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was R605 Mil.
Gross Profit is the numerator in the calculation of Gross Margin.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Ascendis Health (JSE:ASC) has a Gross Profit of R605 Mil as of Jun. 2023. Gross Profit equals net sales less total cost of goods sold. View historical data on Ascendis Health and its competitors.
Is Ascendis Health's Gross Profit too high?
Ascendis Health's current Gross Profit is R605 Mil. Overall, Ascendis Health has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Ascendis Health's Gross Profit compare to PHBI and GCAN?
Ascendis Health's Gross Profit of R605 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Profit for a Medical Distribution company?
A good Gross Profit depends on the Medical Distribution industry context. However, Gross Profit should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Profit mean?
A high Gross Profit can signal that a stock is expensive relative to its fundamentals. Gross Profit equals net sales less total cost of goods sold. View historical data on Ascendis Health and its competitors. Ascendis Health's current Gross Profit is R605 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ascendis Health stock overvalued right now?
Ascendis Health (JSE:ASC) has a current Gross Profit of R605 Mil. The current Gross Profit is R605 Mil. Ascendis Health's overall GF Score™ is 11/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Profit calculated?
Gross Profit is calculated from a company's financial statements. For Ascendis Health (JSE:ASC), the current Gross Profit is R605 Mil as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Ascendis Health Ltd is a health and wellness investment holding Company that holds investments in a number of companies that market and distribute a portfolio of brands, products, and medical devices. The company operates in two segments: i) Consumer Health (wellness, health supplements, speciality ingredients and compounded medicines) and ii) Medical Devices (distributor of medical devices, in vitro diagnostic products and orthopaedic equipment). The company generates the majority of its revenue from the Medical Devices segment.
11GF Score
Get the complete analysis for JSE:ASC
Gross Profit is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JSE:ASC has been successfully added to your 
